|
29.08.2016 10:12:06
|
DGAP-News: M1 Kliniken AG
DGAP-News: M1 Kliniken AG - H1 2016: Preliminary IFRS results, sales EUR 18.5 million, operating result (EBIT) EUR 3.0 million; investments in the expansion of hospital capacities and outpatient services
In the first half-year 2016 M1 Kliniken AG, Berlin (ISIN: DEA0STSQ8), achieved IFRS Group sales of EUR 18.5 million (previous year total: EUR 34.9 million) and an operating result (EBIT) of EUR 3.0 million (previous year total: EUR 7.0 million).
"The clinic in Berlin received on April 14th 2016 the concession for the enlargement to six operating rooms and 34 patient beds. In Germany we are now active with twelve M1-outpatient service centres. The expansion of capacities will allow M1 further growth in the course of the year 2016", says Patrick Brenske, Member of the Management Board of M1 Kliniken AG.
About M1 Klinken AG:
M1 Kliniken AG is one of the leading private providers of health care services in the medical beauty market. M1 group offers products and services "Made in Germany" to customers throughout Germany with a broad spectrum of aesthetic and surgical treatments. Experienced and highly specialised teams of medical specialists use high- class products and state-of-the-art medical technology for minimally invasive surgery and plastic surgery on highest quality standards.
M1 Kliniken AG is listed in the Entry Standard (Open Market) on the Frankfurt Stock Exchange. Key figures for the share of M1 Kliniken AG: Subscribed capital: EUR 15,000,000 Listed shares: bearer shares ISIN: DE000A0STSQ8 WKN: A0STSQ Stock symbol: M12
Contact: M1 Kliniken AG Grünauer Straße 5 D-12557 Berlin Phone: +49 (0)30 887 086 225 Fax: +49 (0)30 887 086 228 E-Mail: ir@m1-kliniken.de Web: www.m1-kliniken.ag
---------------------------------------------------------------------------
29.08.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
---------------------------------------------------------------------------
496491 29.08.2016
DGAP-News: M1 Kliniken AG / Key word(s): Half Year Results/Dividend
M1 Kliniken AG - H1 2016: Preliminary IFRS results, sales EUR 18.5 million,
operating result (EBIT) EUR 3.0 million; investments in the expansion of
hospital capacities and outpatient services
29.08.2016 / 10:12
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Corporate News of M1 Kliniken AG:
H1 2016: Preliminary IFRS results, sales EUR 18.5 million, operating result
(EBIT) EUR 3.0 million; investments in the expansion of hospital capacities
and outpatient services
In the first half-year 2016 M1 Kliniken AG, Berlin (ISIN: DEA0STSQ8), achieved IFRS Group sales of EUR 18.5 million (previous year total: EUR 34.9 million) and an operating result (EBIT) of EUR 3.0 million (previous year total: EUR 7.0 million).
"The clinic in Berlin received on April 14th 2016 the concession for the enlargement to six operating rooms and 34 patient beds. In Germany we are now active with twelve M1-outpatient service centres. The expansion of capacities will allow M1 further growth in the course of the year 2016", says Patrick Brenske, Member of the Management Board of M1 Kliniken AG.
About M1 Klinken AG:
M1 Kliniken AG is one of the leading private providers of health care services in the medical beauty market. M1 group offers products and services "Made in Germany" to customers throughout Germany with a broad spectrum of aesthetic and surgical treatments. Experienced and highly specialised teams of medical specialists use high- class products and state-of-the-art medical technology for minimally invasive surgery and plastic surgery on highest quality standards.
M1 Kliniken AG is listed in the Entry Standard (Open Market) on the Frankfurt Stock Exchange. Key figures for the share of M1 Kliniken AG: Subscribed capital: EUR 15,000,000 Listed shares: bearer shares ISIN: DE000A0STSQ8 WKN: A0STSQ Stock symbol: M12
Contact: M1 Kliniken AG Grünauer Straße 5 D-12557 Berlin Phone: +49 (0)30 887 086 225 Fax: +49 (0)30 887 086 228 E-Mail: ir@m1-kliniken.de Web: www.m1-kliniken.ag
---------------------------------------------------------------------------
29.08.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
---------------------------------------------------------------------------
496491 29.08.2016
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu M1 Kliniken AGmehr Nachrichten
|
19.11.24 |
EQS-News: M1 Kliniken AG increases operating profit (EBIT) by 71% in the first nine months of 2024 and confirms medium-term targets (EQS Group) | |
|
19.11.24 |
EQS-News: M1 Kliniken AG steigert operativen Gewinn (EBIT) um 71 % in den ersten neun Monaten 2024 und bestätigt Mittelfristziele (EQS Group) | |
|
03.09.24 |
EQS-News: Operativer Gewinn (EBIT) fast verdoppelt: M1 Kliniken AG wächst auch in H1 2024 deutlich (EQS Group) | |
|
03.09.24 |
EQS-News: Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first half of 2024 (EQS Group) | |
|
21.06.24 |
EQS-News: M1 Kliniken AG: Management Board confirms growth targets (EQS Group) | |
|
21.06.24 |
EQS-News: M1 Kliniken AG: Vorstand bestätigt Wachstumsziele (EQS Group) | |
|
20.06.24 |
EQS-DD: M1 Kliniken AG: Attila Strauss, Verkauf (EQS Group) | |
|
20.06.24 |
EQS-DD: M1 Kliniken AG: Attila Strauss, sell (EQS Group) |
Analysen zu M1 Kliniken AGmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.